DSGN
Price
$2.94
Change
-$0.20 (-6.37%)
Updated
Apr 8, 04:59 PM (EDT)
Capitalization
178.23M
34 days until earnings call
NTLA
Price
$6.28
Change
-$0.26 (-3.98%)
Updated
Apr 8, 04:59 PM (EDT)
Capitalization
680.11M
23 days until earnings call
Ad is loading...

DSGN vs NTLA

Header iconDSGN vs NTLA Comparison
Open Charts DSGN vs NTLABanner chart's image
Design Therapeutics
Price$2.94
Change-$0.20 (-6.37%)
Volume$3.88K
Capitalization178.23M
Intellia Therapeutics
Price$6.28
Change-$0.26 (-3.98%)
Volume$70.42K
Capitalization680.11M
DSGN vs NTLA Comparison Chart
Loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DSGN vs. NTLA commentary
Apr 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Buy and NTLA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 09, 2025
Stock price -- (DSGN: $3.14 vs. NTLA: $6.54)
Brand notoriety: DSGN and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 142% vs. NTLA: 146%
Market capitalization -- DSGN: $178.23M vs. NTLA: $680.11M
DSGN [@Biotechnology] is valued at $178.23M. NTLA’s [@Biotechnology] market capitalization is $680.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, NTLA is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 5 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • DSGN’s TA Score: 5 bullish, 6 bearish.
  • NTLA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both DSGN and NTLA are a bad buy in the short-term.

Price Growth

DSGN (@Biotechnology) experienced а -18.65% price change this week, while NTLA (@Biotechnology) price change was -8.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.88%. For the same industry, the average monthly price growth was -20.27%, and the average quarterly price growth was -19.68%.

Reported Earning Dates

DSGN is expected to report earnings on May 12, 2025.

NTLA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-9.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($680M) has a higher market cap than DSGN($178M). NTLA YTD gains are higher at: -43.911 vs. DSGN (-49.109). DSGN has higher annual earnings (EBITDA): -61.79M vs. NTLA (-523.98M). NTLA has more cash in the bank: 602M vs. DSGN (245M). DSGN has less debt than NTLA: DSGN (2.33M) vs NTLA (210M). NTLA has higher revenues than DSGN: NTLA (57.9M) vs DSGN (0).
DSGNNTLADSGN / NTLA
Capitalization178M680M26%
EBITDA-61.79M-523.98M12%
Gain YTD-49.109-43.911112%
P/E RatioN/AN/A-
Revenue057.9M-
Total Cash245M602M41%
Total Debt2.33M210M1%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DSGNNTLA
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 7 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
88%
Bullish Trend 16 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VRLCX14.790.05
+0.34%
Voya Large Cap Growth Port R6
FFIMX19.45N/A
N/A
Fidelity Advisor Asset Manager 50% I
JSJCX12.50N/A
N/A
JHancock Small Cap Dynamic Growth C
FCGYX17.07-0.23
-1.33%
NYLI PineStone Global Equity Class C
DLHIX22.12-0.32
-1.43%
Macquarie Healthcare I

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with VRDN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-7.65%
VRDN - DSGN
41%
Loosely correlated
-1.75%
KRYS - DSGN
40%
Loosely correlated
-3.09%
MDGL - DSGN
38%
Loosely correlated
-1.23%
RCKT - DSGN
38%
Loosely correlated
+1.37%
NTLA - DSGN
37%
Loosely correlated
-1.36%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-1.36%
VCYT - NTLA
69%
Closely correlated
+2.00%
CRSP - NTLA
65%
Loosely correlated
-0.83%
BEAM - NTLA
63%
Loosely correlated
+0.20%
RXRX - NTLA
59%
Loosely correlated
-0.94%
ABCL - NTLA
57%
Loosely correlated
-1.91%
More